Karthikeyan Ananthasubramaniam, MD
Enriched profileDirector of Nuclear Cardiology and Cardiac PET Laboratory, Henry Ford Hospital · Henry Ford Health
Karthikeyan Ananthasubramaniam is Director of Nuclear Cardiology and Cardiac PET Laboratory, Henry Ford Hospital at Henry Ford Health. OpenAlex indexes 93 publications with 560 citations (h-index 14); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 14 Oct 2026
Karthikeyan Ananthasubramaniam, M.D., is Director of Nuclear Cardiology and Cardiac PET Laboratory, Henry Ford Hospital at Henry Ford Health. The public record shows 93 publications with 560 citations (h-index 14), centered on Cardiac Imaging and Diagnostics, Cardiovascular Function and Risk Factors, Cardiac tumors and thrombi. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 11 companies.
- Most recent indexed publication: 2025 · Annals of medicine
- Top research focus: Cardiac Imaging and Diagnostics
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 17.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- CPX in Paradoxical Low Flow Aortic Stenosis
Sponsor: Henry Ford Health System
- Safety and Accuracy of Regadenoson-Atropine Stress Echocardiography in CAD
Sponsor: Henry Ford Health System
Industry payments
Updated 14 Oct 2026
11 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.5%Statin19.4%Atorvastatin Calcium67%Rosuvastatin Calcium17%Pravastatin Sodium12%Simvastatin4%Part D<11 patientsBeta blocker17.8%Metoprolol Succinate58%Carvedilol22%Metoprolol Tartrate17%Atenolol4%Part D<11 patients+ 15 more classes in this area
Nervous system
12%Other nervous system drugs12%Vyndamax62%Vyndaqel38%Part D<11 patientsBlood & clotting
10.6%Factor Xa inhibitor7.6%Eliquis83%Xarelto17%Part D<11 patientsP2Y12 inhibitor2%Clopidogrel100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases.
Heart failure reviews
Review2023
Most-cited works
by citation count (OpenAlex)- 01
- 02Coronary Computed Tomography Angiography After Stress TestingArticle69 citations2012
- 03
- 04Epidemiology and clinical manifestations of cardiac amyloidosisArticle45 citations2021
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/karthikeyan-ananthasubramaniam-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/karthik-ananthasubramaniam-46998052
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Karthikeyan-Ananthasubramaniam
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →henryford.com ↗
- Board certified
American Board of Internal Medicine: Cardiovascular Disease and Adult Congenital Heart Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →henryford.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →henryford.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →henryford.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →henryford.com ↗
Secondary affiliations
appointments beyond the home institution- Professor of Medicine
Wayne State University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →henryford.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Philip, MD
Henry Ford Health
David Lanfear, MD
Henry Ford Health
Marvin Eng, MD
Henry Ford Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)